SCHEMBL18739601

SCHEMBL18739601

CC(=O)c1cc(Br)c2nc(N3CCOCC3)cnc2c1

nearest known ligand 0.45

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ PIK3CA P42336 13/20 0.45
▸ PIK3CD O00329 11/20 0.45
▸ PIK3CB P42338 11/20 0.45
▸ PIK3CG P48736 10/20 0.45
▸ MTOR P42345 5/20 0.45
▸ HPGD P15428 2/20 0.40
▸ ALDH1A1 P00352 2/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ HSD17B10 Q99714 1/20 0.40
▸ HDAC6 Q9UBN7 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ PTGS2 P35354 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18739484 0.89 PIK3CA (0.49) PIK3CAPIK3CDPIK3CBPIK3CGMTOR
SCHEMBL18739097 0.87 PIK3CA (0.58) PIK3CAPIK3CDPIK3CBPIK3CGMTOR
SCHEMBL18739092 0.87 PIK3CA (0.46) PIK3CAPIK3CDPIK3CBPIK3CGMTOR
SCHEMBL18739184 0.87 ALDH1A1 (0.52) PIK3CAPIK3CDPIK3CBPIK3CGMTOR
SCHEMBL18739117 0.85 ALDH1A1 (0.47) PIK3CAPIK3CDPIK3CBPIK3CGMTOR
SCHEMBL18739629 0.81 MET (0.47) PIK3CAPIK3CDPIK3CBPIK3CGMTOR
SCHEMBL30808177 0.81 MET (0.47) PIK3CAPIK3CDPIK3CBPIK3CGMTOR
SCHEMBL18739603 0.81 PIK3CD (0.41) PIK3CAPIK3CDPIK3CBPIK3CGMTOR
SCHEMBL18739760 0.81 KMT2A (0.46) PIK3CAPIK3CDPIK3CBPIK3CGMTOR
SCHEMBL18739162 0.81 PIK3CB (0.67) PIK3CAPIK3CDPIK3CBPIK3CGMTOR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3359533-B1 QUINOXALINE AND PYRIDOPYRAZINE DERIVATIVES AS PI3KBETA INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2021-11-17 — — EP disclosed
WO-2017060406-A1 QUINOXALINE AND PYRIDOPYRAZINE DERIVATIVES AS PI3KBETA INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2017-04-13 — — WO disclosed
Send feedback